Aqueous chlorination of diclofenac: Kinetic study and transformation products identification

Water Research

Volumn 46, Issue 10, 2012, Pages 3377-3386

  Soufan, M ^a   Deborde, M ^a,b   Legube, B ^a  

^a UNIVERSITÉ DE POITIERS   (France)

^b UNIVERSITÉ DE POITIERS   (France)

Author keywords

By products; Chlorination; Diclofenac; Kinetic; Mechanism; Pharmaceuticals

Indexed keywords

CHLORINATION; CHLORINE; CHLORINE COMPOUNDS; DEGRADATION; IONIZATION; RATE CONSTANTS;

DICLOFENAC; FIRST ORDER; HYPOCHLOROUS ACIDS; KINETIC STUDY; KINETIC TRANSFORMATION; PH RANGE; PRODUCT IDENTIFICATION; TOTAL CHLORINE; TRANSFORMATION PRODUCTS; WATER CHLORINATION;

KINETICS;

DICLOFENAC;

CHLORINATION; CHLORINE; CONCENTRATION (COMPOSITION); DEGRADATION; DRUG; IDENTIFICATION METHOD; PH; REACTION KINETICS; TRANSFORMATION;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL REACTION; CHEMICAL STRUCTURE; CHLORINATION; DEGRADATION; PH; PRIORITY JOURNAL; WATER ANALYSIS; WATER TREATMENT;

EID: 84861197354     PISSN: 00431354     EISSN: 18792448     Source Type: Journal    
DOI: 10.1016/j.watres.2012.03.056     Document Type: Article

References (35)

1. Albert A., Serjeant E.P. The Determination of Ionization Constants. A Laboratory Manual 1984, Chapman and Hall, New York. third ed.
2. Benotti M.J., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environmental Science and Technology 2009, 43:597-603.
3. Boyd G.R., Reemtsma H., Grimm D.A., Mitra S. Pharmaceuticals and personal care products in surface and treated waters of Louisiana USA and Ontario, Canada. Journal of Science of the Total Environment 2003, 311:135-149.
4. Carlsson C., Johansson A.K., Alvan G., Bergman K., Kühler T. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients. Journal of Science of the Total Environment 2006, 364:67-87.
5. Coelho A.D., Sans C., Agüera A., Gómez M.J. Effects of ozone pre-treatment on diclofenac: intermediates, biodegradability and toxicity assessment. Journal of Science of the Total Environment 2009, 407:3572-3578.
6. Deborde M., von Gunten U. Reactions of chlorine with inorganic and organic compounds during water treatment - kinetics and mechanisms: a critical review. Journal of Water Research 2008, 42:13-51.
7. Dodd M.C., Huang C.H. Transformation of antibacterial agent sulfamethoxazole in reaction with chlorine: kinetics, mechanisms and pathways. Environmental Science and Technology 2004, 38:5607-5615.
8. Fishbein J.C., McClelland R.A. Halide ion trapping of nitrenium ions formed in the Bamberger rearrangement of N-arylhydroxylamines. Lifetime of the parent phenylnitrenium ion in water. Canadian Journal of Chemistry 1996, 74:1321-1328.
9. Gassman P.G., Campbell G.A. The mechanism of the chlorination of anilines and related aromatic amines. The involvement of nitrenium ions. Journal of the American Chemical Society 1971, 93:2567-2569.
10. Hernando M.D., Mezcua M., Fernandez-Alba A.R., Barcelo D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Journal of Talanta 2006, 69:334-342.
11. Huber M.M., Canonica S., Park G.Y., von Gunten U. Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Journal of Environmental Science and Technology 2003, 37:1016-1024.
12. Jones O.A.H., Voulvoulis N., Lester J.N. Potential impact of pharmaceuticals on environmental health. Journal of Bulletin of the World Health Organization 2003, 81:768-769.
13. Joss A., Zabczynski S., Göbel A., Hoffman B., Löffler D., McArdell C.S., Ternes T.A., Thomsen A., Siegrist H. Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Journal of Water Research 2006, 40:1686-1696.
14. Metcalfe C.D., Miao X.S., Servos M. Pharmaceuticals in the Canadian environment. Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks 2004, 67-90. Springer, Berlin, Heidelberg, New York. K. Kümmerer (Ed.).
15. Miyamoto G., Zahid N., Uetrecht J.P. Oxidation of diclofenac to Reactive intermediates by Neutrophils, Myeloperoxidase, and hypochlorous acid. Journal of Chemical Research in Toxicology 1997, 10:414-419.
16. Mompelat S., Leblot B., Thomas O. Occurrece and fate of pharmaceutical products and by-products from resource to drinking water. Journal of Environmental International 2008, 35:803-814.
17. Oaks J.L., Gilbert M., Virani M.Z., Watson R.T., Meteyer C.U., Rideout B.A., Shivaprasad H.L., Ahmed S., Chaudhry M.J.I., Arshad M., Mahmoud S., All A., Khan A.A. Diclofenac residues as the cause of vulture population decline in Pakistan. Journal of Nature 2004, 427:630-633.
18. Paffoni C., Welte B., Gousailles M., Montiel A. Nouvelles molécules mises en cause par les directives européennes: de la station d'épuration à l'usine de traitement d'eau potable. Journal of Européen d'Hydrologie 2006, 37:21-37.
19. Quintana J.B., Rodil R., Lopez-Mahia P., Muniategui-Lorenzo S., Prada-Rodriguez D. Investigating the chlorination of acidic pharmaceuticals and by-product formation aided by an experimental design methodology. Journal of Water Research 2010, 44:243-255.
20. Rodier J., Legube B., Merlet N. L'analyse de l'eau. Analysis of the water 2009, Dunod, Paris.
21. Rosal R., Rodriguez A., Perdigon-Melon J.A., Petre A., Garcia-Calvo E., Gomez M.J., Aguera A., Fernandez-Alba A.R. Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Journal of Water Research 2010, 44:578-588.
22. Schwaiger J., Ferling H., Mallow U., Wintermayr H., Negele R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac: Part I. Histopathological alterations and bioaccumulation in rainbow trout. Aquatic Toxicology 2004, 68:141-150.
23. Sein M.M., Zedda M., Tuerk J., Schmidt T.C., Golloch A., von Sonntag C. Oxidation of diclofenac with ozone in aqueous solution. Environmental Science and Technology 2008, 42:6656-6662.
24. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Journal of Water Research 1998, 32:3245-3260.
25. Ternes T.A., Meisenheimer M., McDowell D., Sacher F., Brauch H.J., Haist-Gulde B., Preuss G., Wilme U., Zulei-Seibert N. Removal of pharmaceuticals during drinking water treatment. Journal of Environmental Science and Technology 2002, 36:3855-3863.
26. d) for pharmaceuticals and musk fragrance in sewage sludge. Journal of Water Research 2004, 38:4075-4084.
27. Togola A., Budzinski H. Multi-residue analysis of pharmaceutical compounds in aqueous samples. Journal of Chromatography A 2008, 1177:150-158.
28. Triebskorn R., Casper H., Heyd A., Eikemper R., Kohler H.R., Schwaiger J. Toxic effects of non-steroidal anti-inflammatory drug diclofenac: Part II. Cytological effects in liver, kidney, gills and intestie of rainbow trout (Oncorhynchus mykiss). Aquatic Toxicology 2004, 68:151-166.
29. Vaidyanathan G., Wilson J.W. Reaction of cyclopropanamines with hypochlorite. Journal of Organic Chemistry 1989, 54:1815-1820.
30. 2 and ozone. Journal of Water Research 2004, 38:414-422.
31. Wang T.X., Margerum D.W. Kinetics of reversible chlorine hydrolysis: temperature dependence and general-acid/base assisted mechanisms. Journal of Inorganic Chemistry 1994, 33:1050-1055.
32. Webb S., Ternes T., Gibert M., Olejniczak K. Indirect human exposure to pharmaceuticals via drinking water. Toxicology Letters 2003, 142:157-167.
33. Westerhoff P., Yoon Y., Snyder S., Wert E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Journal of Environmental Science and Technology 2005, 39:6649-6663.
34. Wiegel S., Aulinger A., Brockmeyer R., Harms H., Löffler J., Reincke H., Schmidt R., Stachel B., von Tümpling W., Wanke A. Pharmaceuticals in the river Elbe and its tributaries. Journal of Chemosphere 2004, 57:107-126.
35. Zuccato E., Calamari D., Natangelo M., Fanelli R. Presence of therapeutic drugs in the environment. Journal of The Lancet 2000, 355:1789-1790.